stella
beta
Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO — Stella
Recruiting
Back to Thyroid Associated Ophthalmopathies trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
Shanghai Changzheng Hospital, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov